This meta-analysis challenges the randomized FRAIL-AF results, but caution is needed when reconciling the discrepant findings ...

Researchers from the Japan Advanced Institute of Science and Technology, in collaboration with Daiichi Sankyo and the ...

A joint research team led by Professor Eijiro Miyako of the Japan Advanced Institute of Science and Technology (JAIST), in ...

Q2 2025 U.S. Net Product Revenue Grew 42% Y/Y to $40.3 Million -- Total Retail Prescription Equivalents Increased 10% from First Quarter -- Reached Settlement Agreements with Three ANDA Filers Not to ...

A joint research team led by Professor Eijiro Miyako of the Japan Advanced Institute of Science and Technology (JAIST), in ...

A joint research team led by Professor Eijiro Miyako of the Japan Advanced Institute of Science and Technology (JAIST), in ...

Soligenix's HyBryte (synthetic hypericin) offers a promising solution as a potential first-line therapy for early-stage CTCL. By addressing this critical gap in care, HyBryte has the potential to ...

The neuroendocrine prostate cancer treatment space will experience significant changes during the forecast period of 2025–2034, owing to the launch o ...

Antibody-drug conjugates are currently being investigated in more than 260 clinical trials.“It’s going to be the next novel ...

As America's population ages, chronic and rare diseases are emerging as a pressing healthcare challenge — one that ...

According to reports from U.S. CN... Daiichi Sankyo invests 223 billion won in Enhertu production facility in China Japanese pharmaceutical company Daiichi Sankyo, which recorded annual sales of 4 ...